Retatrutide 10mg
€113.01
Retatrutide 10mg research-grade lyophilized peptide powder in a glass vial. Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation.
Research Use Only: Laboratory research use only. Not for human or veterinary use.
Third-Party Tested
This product is third-party tested — view the certificate of analysis and laboratory verification.
Recommended solvent — Bacteriostatic water
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water.
Research Overview
Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously. It is used in laboratory and preclinical models to study integrated control of body weight, glucose homeostasis and whole-body energy balance, without implying any therapeutic or clinical use.
Primary Research Areas
- Triple GIP/GLP-1/glucagon receptor agonism: Mechanistic studies dissecting receptor pharmacology, biased signaling and downstream pathways triggered by combined incretin and glucagon receptor activation.
- Obesity & body-weight regulation models: In vivo models exploring changes in body weight, adiposity, food intake and energy expenditure under Retatrutide-driven multi-agonist signaling.
- Glycemic control & metabolic health: Research focused on glucose tolerance, insulin dynamics, hepatic glucose output and broader metabolic homeostasis in preclinical systems.
Lab data
| Purity: | 99%+ (HPLC, third-party tested) |
| Form: | Lyophilized peptide powder |
| Content: | 10mg Retatrutide per vial |
| Packaging: | Glass vial with sterile closure |
| Storage: | Store lyophilized at 2–8 °C (desiccated, protect from light) |
| Molecular formula: | C221 H342 N46 O68 |
| Molecular weight: | ~4731.4 g·mol⁻¹ |
| Sequence: | Multidomain incretin/glucagon analog (GIP/GLP-1/glucagon triple agonist) peptide backbone with C20 fatty diacid and γGlu–(AEEA)2 side chain for extended PK (Retatrutide, LY3437943). |
| CAS number: | 2381089-83-2 |
Warning
This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.
Comments (0)
No customer reviews for the moment.
